Ignite Creation Date:
2024-05-06 @ 12:45 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03833934
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2019-01-28
Brief Title:
Study of Plasma NGS for Assessment Characterization Evaluation of Patients With ALK Resistance
Sponsor:
Organization:
Addario Lung Cancer Medical Institute
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Blood specimens will be tested for genetic mutations in ALK and other genes that may be important for lung cancer The participant and their doctor will receive a copy of the test results The test results will describe the gene alterations that are detected in the blood sample The assay covers a region of the ALK gene and other lung cancer genes where resistance alterations can occur
Enrollment Count:
120
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 53887 |
Who Masked List: